即时询价 ×
* 必填项
请填妥以下表格,您将在一分钟内得到邮件机器人给你的报价。
Inquiry Online
×
* Required Fields.
Please complete the form below and we will contact you shortly.
Bulk Inquiry
×
* Required Fields.
Please complete the form below and we will contact you shortly.
CAS号 | 915095-99-7 | 货号 | BCP17275 |
中文名 | 乙酰恩格列净 | ||
英文名 | Acetoxy Empagliflozin | ||
中文别名 | |||
英文别名 | BI10773; BI-10773; BI 10773; CE0108; CS0940; PB23119; VA10802; AJ93046; | ||
SMILES | |||
化学名称 | |||
分子式 | C30H33ClO11 | 分子量 | 605.03 |
纯度 | 98% | 配送 | 惯例下常温包邮 |
产品描述 | Empagliflozin, also known as BI10773 (trade name Jardiance), is drug approved for the treatment of type 2 diabetes in adults in 2014. It was developed by Boehringer Ingelheim and Eli Lilly and Company. Empagliflozin is an inhibitor of the sodium glucose co-transporter-2 (SGLT-2), and causes sugar in the blood to be absorbed by the kidneys and eliminated in urine. Empagliflozin is an inhibitor of the sodium glucose co-transporter-2 (SGLT-2), which is found almost exclusively in the proximal tubules of nephronic components in the kidneys. SGLT-2 accounts for about 90 percent of glucose reabsorption into the blood. |
相关产品推荐
查看更多 >Tags:Acetoxy Empagliflozin 供应商,Acetoxy Empagliflozin 购买,Acetoxy Empagliflozin 生产,Acetoxy Empagliflozin 批量,Acetoxy Empagliflozin 供应,Acetoxy Empagliflozin 订购,Acetoxy Empagliflozin 采购